Highlights
A collection of news and information related to Hepatitis C published by this site and its partners.
Displaying items 1-12 of 103
» View wsbt.com items only
1
2
3
4
5
6
7
8
9
•
Next >
-
SPECIAL REPORT: Teens & Tats ... Paying the price
WSBT-TV Anchor/ReporterAs tattoos have become more mainstream in our culture, more and more teens at younger and younger ages are hitting up their parents to be inked. But there are so many considerations besides just age, including health considerations. And one of the...Tags: Family, Hepatitis, Health, Diseases and Illnesses
-
Ky. weighed politics, medicine in inmate's surgery
LOUISVILLE, Ky. (AP) — A condemned killer's fight to receive surgery for agonizing hip pain pushed Kentucky officials into an uncomfortable debate over security, politics and even the possibility of inviting scorn from Fox News pundits. Emails...
Tags: Hip Replacement, Steve Beshear, Hospitals and Clinics, Medical Procedures and Tests, Trials
-
CDC to baby boomers: Get tested for hepatitis C
ATLANTA (AP) — For the first time, the government is proposing that all baby boomers get tested for hepatitis C. Anyone born from 1945 to 1965 should get a one-time blood test to see if they have the liver-destroying virus, the Centers for...Tags: U.S. Centers for Disease Control and Prevention, Vertex Pharmaceuticals Incorporated, General Practitioners, Medical Procedures and Tests, Viral Diseases and Infections
-
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
Reuters* Novartis' one-third stake in Roche built up under Vasella * Vasella exit, retirement of Roche chairman could thaw relations * Roche seen as most likely buyer for the stake * Could make offer in second half of this year - analyst By Caroline...Tags: Shareholders, Earnings, Merck & Company Incorporated, Drugs and Medicines, Voting
-
Experimental Gilead drug effective in early-stage leukemia trial
ReutersBy Deena Beasley May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's biggest...Tags: HIV, Dana-Farber Cancer Institute, Trials, Medical Research, Medical Specialization
-
Yale Researchers Urge More Street Work When Studying People With Both HIV, Hepatitis C
The Hartford CourantResearchers need to work harder to screen high-risk populations for people who are infected with both HIV and hepatitis C, say the authors of a new Yale University study on the incidence of co-infection in the New Haven area. The study, published Tuesday...Tags: U.S. Centers for Disease Control and Prevention, Liver Disease, Drugs and Medicines, Yale University, New Britain
-
Vertex posts quarterly loss as hepatitis C drug sales fall
ReutersApril 30 (Reuters) - Vertex Pharmaceuticals Inc on Tuesday reported a fourth successive quarterly loss as sales of its hepatitis C drug, Incivek, continued to plunge, but the biotechnology company raised its forecast for sales of a cystic fibrosis drug...Tags: Biotechnology, Vertex Pharmaceuticals Incorporated, Biotechnology Industry, Chemical Industry, Science and Technology
-
Abbvie says Chief Scientific Officer John Leonard to retire
ReutersMay 10 (Reuters) - AbbVie Inc's chief scientific officer will be retiring in the next few months and will be involved in the process of naming a successor, the pharmaceutical company said in a regulatory filing on Friday. Chief Scientific Officer John M....Tags: Chemical Industry, Pharmaceuticals, Science and Technology, Rheumatoid Arthritis, Humira (drug)
-
Muchos estadounidenses no se realizan el examen adecuado para la hepatitis C: CDC
ReutersPor Julie Steenhuysen NUEVA YORK (Reuters) - Funcionarios de salud pública de Estados Unidos informaron que sólo la mitad de la población que alguna vez estuvo infectada con el virus de la hepatitis C se realizó la prueba de detección adecuada...Tags: U.S. Centers for Disease Control and Prevention, Viral Diseases and Infections, Diseases and Illnesses, Disease Prevention
-
Many with hepatitis C don't get needed follow-up tests, CDC says
Half of all patients who have tested positive for hepatitis C have not had follow-up testing to see if they are still infected, according to the Centers for Disease Control and Prevention. That means many people are living with the disease and not...
Tags: U.S. Centers for Disease Control and Prevention, Liver Cancer, Medical Procedures and Tests, Hepatitis, Cirrhosis
-
Many in U.S. don't get proper testing for hepatitis C- CDC
ReutersBy Julie Steenhuysen NEW YORK, May 8 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, according to U.S. health officials. Proper testing is a two-...Tags: U.S. Centers for Disease Control and Prevention, Vertex Pharmaceuticals Incorporated, Merck & Company Incorporated, Drugs and Medicines, Medical Procedures and Tests
-
REUTERS SUMMIT-Biotech firms evolve from targets to acquirers
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Skyrocketing valuations quash talks * With financing available, many biotechs go it alone * Bankers expect steady flow of $1 bln to $5 bln pharma deals By...Tags: JPMorgan Chase & Co., Business Enterprises, Macular Degeneration, Companies and Corporations, Economy, Business and Finance
May 4, 2012
|Story| WSBT-TV
May 17, 2012
|Story| AP Broadcast
May 18, 2012
|Story| AP Broadcast
May 16, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 14, 2013
|Story| Hartford Courant
Apr 30, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 8, 2013
|Story| Los Angeles Times
May 8, 2013
|Story| Reuters
May 7, 2013
|Story| Reuters
Original site for Hepatitis C topic gallery.